Apollo Pharmacy aims for 10 crore customers in five years, plans two stores every day

Apollo Pharmacy has announced an ambitious growth strategy: it aims to reach 10 crore customers within the next five years, while opening two new stores every day to deepen its presence in neighbourhood healthcare across India. The plan appears focused on expanding beyond metro centres into smaller towns and previously underserved areas.

As of late 2025, Apollo has over 7,000 stores across the country, reflecting its widespread footprint. Apollo HealthCo, the arm that runs its pharmacy and digital‑health operations, serves customers across more than 19,000 pin codes, and reportedly handles over one million orders every day. The company's loyalty programme, Apollo Circle, has also crossed 10 million members, indicating substantial digital engagement.

On the financial front, Apollo HealthCo’s recent results show meaningful scale. In Q4 FY25, the company reported offline pharmacy distribution revenue of about ₹2,084 crore and digital platform revenue of around ₹292 crore. Its overall HealthCo segment revenue for FY25 stood at approximately ₹9,093 crore, reflecting strong growth across both its retail pharmacy network and digital health services.

Despite this strong base, the company has not revealed where exactly the two new stores per day will open. Industry observers surmise most new outlets will be in tier‑2 and tier‑3 towns with weaker organised‑pharmacy penetration, or in suburban/semi‑urban zones of larger cities, rather than in saturated urban neighbourhoods. This, they believe, will help avoid cannibalising existing stores.

However, sustaining such rapid expansion comes with its own set of challenges. Every new store demands capital investment, inventory stocking, skilled staff, and timely regulatory clearances, pressures that intensify when scaled across hundreds of outlets. The company must also maintain a strong supply chain and tight operational discipline to ensure stores move toward profitability. It is equally possible that the current strategy prioritizes rapid market capture first, with store-level profitability taking a backseat in the initial phase.

Reaching 10 crore unique customers within five years remains a highly ambitious target. While Apollo already records over a million orders daily and has a strong loyalty‑programme base, growth to 100 million unique customers will require deep penetration into under‑served markets, efficient integration of physical and digital channels, and strong retention, especially among chronic or repeat medicine users. With shifting consumer behaviour and rising online competition, success depends heavily on execution and favourable market conditions.

Apollo’s expansion plan underscores its commitment to making quality medicines broadly accessible, but the scale and pace make the goal both bold and challenging. Whether serial store openings, rising revenues, and digital engagement will translate into 10 crore customers is a question of how well the company navigates operational, regulatory and competitive headwinds.